2023 Poster Presentations
P01: Next-Generation EpiScreen® Immunogenicity Assay, Presented by Mercedes PO., Abzena (Cambridge) Ltd.
P02: Anti-Drug Antibody (ADA) Assay Development Using Automated GyroLab® Immunoassay System, Presented by Sally Y., Boehringer Ingelheim Pharmaceuticals, Inc.
P03: Generic ADA Assay for Accelerated Measurement of Immune Complexes Using the Gyrolab Platform, Presented by Ellen L., Gyros Protein Technologies
P04: Advanced MAPPS Leads to Reliable Immunogenicity Risk Assessment of Biotherapeutics, Presented by Elise P., ImmuneSpec BV
P05: In Silico and In Vitro Assays to Assess Unwanted Immunogenicity, Presented by Sofie P., ImmunXperts, a Q2 Solutions company
P06: Assay Development and Optimization to Measure the Titers of Anti-PEG Immunoglobulin Isotypes in Human Serum, Presented by Weiping C., Moderna, Inc.
P07: Development of an iLite® Reporter Cell Platform for the Quantification of Anti-AAV Neutralizing Antibodies, Presented by Jordi RM., Svar Life Science
P08: Quantification of ADCP Activity of Therapeutic Antibodies Using Engineered Effector Cells and Target Cells, Presented by Jordi RM., Svar Life Science
P09: Development of a Highly Sensitive ADCC iLite® Reporter Gene Assay with True MoA-Reflecting Properties, Presented by Michael S., Svar Life Science
P10: Development of a New Class of Target Cell Lines to Evaluate Fc-Mediated Cytotoxicity, Presented by Michael T., Svar Life Science
P11: Differentially Expressed Genes in Atopic Dermatitis: Bioinformatics Analysis of Pooled Microarray Gene Expression Datasets in Gene Expression Omnibus, Presented by Danna J., Washington Institute for Health Sciences